Achaogen (AKAO) Inventory Turnover Ratio, from fourth quarter 2018 to fourth quarter 2017, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Achaogen, Inc.  (AKAO)
 

Achaogen Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Achaogen's inventory turnover ratio, the ratio that measures Achaogen's ability to manage its supply chain, sequentially decreased to 16.44 in the fourth quarter 2018, but it does not raise any concerns as Achaogen continue to execute well, and the inventory turnover ratio remains above the average. Achaogen's average inventory processing period in the Dec 31 2018 quarter, has increased to 22 days, from 12 days, in the Sep 30 2018 quarter.

Within Healthcare sector Achaogen, Inc. achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the fourth quarter 2018 compared to previous quarter at no. .

AKAO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Achaogen, Inc. Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AKAO Inventory Turnover Ratio (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter		 (Dec 31 2017)
IV. Quarter
Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth - - - - -
Inventory Turnover Ratio (TTM) 16.44 29.61 - - -
AKAO's Total Ranking # # # # #
Average inventory processing period 22 12 - - -
Seq. Inventory Growth -19.15 % - - - -
Seq. Cost of Sales Growth 81.82 % -99.57 % 19.55 % - -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
0 0 0
 



AKAO Company Profile >> Back to AKAO Efficiency Comparisons >> Compare AKAO Inventory Turnover Ratio to its Competitors

Financial Statements
Achaogen's Inventories $ 1 Millions Visit AKAO's Balance sheet
Achaogen's Cost of Revenues TTM $ 5 Millions Visit AKAO's Income Statement
What are AKAO's Sales? Visit AKAO's Sales by Segment

Other Inventory Turnover Ratios
Achaogen's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AKAO's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AKAO's Competitors
Inventory Turnover Ratio for AKAO's Suppliers
Inventory Turnover Ratio for AKAO's Customers

You may also want to know
AKAO's Sales Growth Rates AKAO's Pe Price to earnings ratio AKAO's Receivables Turnover Ratio AKAO's Stock Quote
AKAO's Net Income Growth Rates AKAO's Ps Price to Sales ratio AKAO's Sales per Employee AKAO's Asset Turnover Ratio
AKAO's Net Margin AKAO's Pb Price to Book ratio AKAO's Financial Strength Ratios AKAO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2018, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2018 Inventories at quarter ending Dec 31 2018
Jrsis Health Care Corp  23.93 $ 28.403  Millions$ 1  Millions
Rennova Health Inc   21.98 $ 11.510  Millions$ 1  Millions
Vanda Pharmaceuticals Inc   20.08 $ 20.508  Millions$ 1  Millions
Fortress Biotech Inc   20.05 $ 9.388  Millions$ 0  Millions
Heartbeam Inc   19.75 $ 148.986  Millions$ 8  Millions
Fonar Corporation  19.09 $ 30.427  Millions$ 2  Millions
Inotiv Inc   18.62 $ 20.098  Millions$ 1  Millions
Irhythm Holdings Inc   18.36 $ 38.579  Millions$ 2  Millions
Biocept Inc   18.30 $ 10.052  Millions$ 1  Millions
Incyte Corporation  16.05 $ 94.123  Millions$ 6  Millions
Option Care Health Inc   15.98 $ 465.865  Millions$ 29  Millions
Collegium Pharmaceutical Inc   15.95 $ 165.677  Millions$ 10  Millions
China Yct International Group, Inc.  15.65 $ 43.342  Millions$ 3  Millions
Clearday Inc   15.21 $ 2.445  Millions$ 0  Millions
Opko Health Inc   15.06 $ 686.095  Millions$ 46  Millions
Precipio inc   15.04 $ 2.639  Millions$ 0  Millions
Motus Gi Holdings Inc   14.78 $ 0.632  Millions$ 0  Millions
Nutriband Inc   14.64 $ 0.245  Millions$ 0  Millions
Star Equity Holdings Inc   14.64 $ 84.312  Millions$ 6  Millions
Puma Biotechnology Inc   12.97 $ 34.621  Millions$ 3  Millions
Natera Inc   12.62 $ 158.081  Millions$ 13  Millions
Vaso Corporation  12.40 $ 25.998  Millions$ 2  Millions
Rockwell Medical inc   11.81 $ 64.223  Millions$ 5  Millions
Zai Lab Limited  11.27 $ 0.044  Millions$ 0  Millions
Hutchmed china Limited  11.10 $ 129.346  Millions$ 12  Millions
Medifocus Inc.  11.08 $ 1.085  Millions$ 0  Millions
Align Technology inc   11.06 $ 518.625  Millions$ 47  Millions
Aeon Global Health Corp.  10.54 $ 4.446  Millions$ 0  Millions
Hanger inc.  9.87 $ 682.624  Millions$ 69  Millions
Cytosorbents Corporation  9.78 $ 7.489  Millions$ 1  Millions

Date modified: 2026-09-08T15:09:33+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.